Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours (MACRO-2)
This study is ongoing, but not recruiting participants.
Study NCT01161316
Information provided by Spanish Cooperative Group for Gastrointestinal Tumour Therapy
First Received on July 12, 2010.
Last Updated on February 19, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
